Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Research Report 2020
SKU ID : QYR-15308833 | Publishing Date : 18-Feb-2020 | No. of pages : 117
Detailed TOC of Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Research Report 2020
Table of Contents1 Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Overview
1.1 Product Overview and Scope of Benign Prostatic Hyperplasia (BPH) Treatment Devices
1.2 Benign Prostatic Hyperplasia (BPH) Treatment Devices Segment by Type
1.2.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Production Growth Rate Comparison by Type 2020 VS 2026
1.2.2 Laser Based Procedure
1.2.3 Other Energy Based Procedure
1.3 Benign Prostatic Hyperplasia (BPH) Treatment Devices Segment by Application
1.3.1 Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumption Comparison by Application: 2020 VS 2026
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Specialty Clinics
1.3.5 Other
1.4 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market by Region
1.4.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size Estimates and Forecasts by Region: 2020 VS 2026
1.4.2 North America Estimates and Forecasts (2015-2026)
1.4.3 Europe Estimates and Forecasts (2015-2026)
1.4.4 China Estimates and Forecasts (2015-2026)
1.4.5 Japan Estimates and Forecasts (2015-2026)
1.5 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Growth Prospects
1.5.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Estimates and Forecasts (2015-2026)
1.5.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Production Capacity Estimates and Forecasts (2015-2026)
1.5.3 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Production Estimates and Forecasts (2015-2026)
2 Market Competition by Manufacturers
2.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Production Capacity Market Share by Manufacturers (2015-2020)
2.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Share by Manufacturers (2015-2020)
2.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.4 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Average Price by Manufacturers (2015-2020)
2.5 Manufacturers Benign Prostatic Hyperplasia (BPH) Treatment Devices Production Sites, Area Served, Product Types
2.6 Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Competitive Situation and Trends
2.6.1 Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Concentration Rate
2.6.2 Global Top 3 and Top 5 Players Market Share by Revenue
2.6.3 Mergers & Acquisitions, Expansion
3 Production Capacity by Region
3.1 Global Production Capacity of Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Share by Regions (2015-2020)
3.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Regions (2015-2020)
3.3 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.4 North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Production
3.4.1 North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Production Growth Rate (2015-2020)
3.4.2 North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.5 Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Production
3.5.1 Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Production Growth Rate (2015-2020)
3.5.2 Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.6 China Benign Prostatic Hyperplasia (BPH) Treatment Devices Production
3.6.1 China Benign Prostatic Hyperplasia (BPH) Treatment Devices Production Growth Rate (2015-2020)
3.6.2 China Benign Prostatic Hyperplasia (BPH) Treatment Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.7 Japan Benign Prostatic Hyperplasia (BPH) Treatment Devices Production
3.7.1 Japan Benign Prostatic Hyperplasia (BPH) Treatment Devices Production Growth Rate (2015-2020)
3.7.2 Japan Benign Prostatic Hyperplasia (BPH) Treatment Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)
4 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumption by Regions
4.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumption by Regions
4.1.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumption by Region
4.1.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumption Market Share by Region
4.2 North America
4.2.1 North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumption by Countries
4.2.2 U.S.
4.2.3 Canada
4.3 Europe
4.3.1 Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumption by Countries
4.3.2 Germany
4.3.3 France
4.3.4 U.K.
4.3.5 Italy
4.3.6 Russia
4.4 Asia Pacific
4.4.1 Asia Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumption by Region
4.4.2 China
4.4.3 Japan
4.4.4 South Korea
4.4.5 Taiwan
4.4.6 Southeast Asia
4.4.7 India
4.4.8 Australia
4.5 Latin America
4.5.1 Latin America Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumption by Countries
4.5.2 Mexico
4.5.3 Brazil
5 Production, Revenue, Price Trend by Type
5.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Production Market Share by Type (2015-2020)
5.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Type (2015-2020)
5.3 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Price by Type (2015-2020)
5.4 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
6 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Analysis by Application
6.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumption Market Share by Application (2015-2020)
6.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumption Growth Rate by Application (2015-2020)
7 Company Profiles and Key Figures in Benign Prostatic Hyperplasia (BPH) Treatment Devices Business
7.1 Endo International (US)
7.1.1 Endo International (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Production Sites and Area Served
7.1.2 Endo International (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Introduction, Application and Specification
7.1.3 Endo International (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.1.4 Endo International (US) Main Business and Markets Served
7.2 Karl Storz (Germany)
7.2.1 Karl Storz (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Production Sites and Area Served
7.2.2 Karl Storz (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Introduction, Application and Specification
7.2.3 Karl Storz (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.2.4 Karl Storz (Germany) Main Business and Markets Served
7.3 Medtronic (US)
7.3.1 Medtronic (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Production Sites and Area Served
7.3.2 Medtronic (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Introduction, Application and Specification
7.3.3 Medtronic (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.3.4 Medtronic (US) Main Business and Markets Served
7.4 Siemens (Germany)
7.4.1 Siemens (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Production Sites and Area Served
7.4.2 Siemens (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Introduction, Application and Specification
7.4.3 Siemens (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.4.4 Siemens (Germany) Main Business and Markets Served
7.5 Lumenis (Israel)
7.5.1 Lumenis (Israel) Benign Prostatic Hyperplasia (BPH) Treatment Devices Production Sites and Area Served
7.5.2 Lumenis (Israel) Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Introduction, Application and Specification
7.5.3 Lumenis (Israel) Benign Prostatic Hyperplasia (BPH) Treatment Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.5.4 Lumenis (Israel) Main Business and Markets Served
7.6 Olympus (Japan)
7.6.1 Olympus (Japan) Benign Prostatic Hyperplasia (BPH) Treatment Devices Production Sites and Area Served
7.6.2 Olympus (Japan) Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Introduction, Application and Specification
7.6.3 Olympus (Japan) Benign Prostatic Hyperplasia (BPH) Treatment Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.6.4 Olympus (Japan) Main Business and Markets Served
7.7 Urologix (US)
7.7.1 Urologix (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Production Sites and Area Served
7.7.2 Urologix (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Introduction, Application and Specification
7.7.3 Urologix (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.7.4 Urologix (US) Main Business and Markets Served
7.8 NeoTract (US)
7.8.1 NeoTract (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Production Sites and Area Served
7.8.2 NeoTract (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Introduction, Application and Specification
7.8.3 NeoTract (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.8.4 NeoTract (US) Main Business and Markets Served
7.9 Boston Scientific (US)
7.9.1 Boston Scientific (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Production Sites and Area Served
7.9.2 Boston Scientific (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Introduction, Application and Specification
7.9.3 Boston Scientific (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.9.4 Boston Scientific (US) Main Business and Markets Served
7.10 Urotech (Germany)
7.10.1 Urotech (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Production Sites and Area Served
7.10.2 Urotech (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Introduction, Application and Specification
7.10.3 Urotech (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.10.4 Urotech (Germany) Main Business and Markets Served
7.11 Toshiba (Japan)
7.11.1 Toshiba (Japan) Benign Prostatic Hyperplasia (BPH) Treatment Devices Production Sites and Area Served
7.11.2 Toshiba (Japan) Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Introduction, Application and Specification
7.11.3 Toshiba (Japan) Benign Prostatic Hyperplasia (BPH) Treatment Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.11.4 Toshiba (Japan) Main Business and Markets Served
7.12 Baxter International (US)
7.12.1 Baxter International (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Production Sites and Area Served
7.12.2 Baxter International (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Introduction, Application and Specification
7.12.3 Baxter International (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.12.4 Baxter International (US) Main Business and Markets Served
8 Benign Prostatic Hyperplasia (BPH) Treatment Devices Manufacturing Cost Analysis
8.1 Benign Prostatic Hyperplasia (BPH) Treatment Devices Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Raw Materials Price Trend
8.1.3 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Benign Prostatic Hyperplasia (BPH) Treatment Devices
8.4 Benign Prostatic Hyperplasia (BPH) Treatment Devices Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Benign Prostatic Hyperplasia (BPH) Treatment Devices Distributors List
9.3 Benign Prostatic Hyperplasia (BPH) Treatment Devices Customers
10 Market Dynamics
10.1 Market Trends
10.2 Opportunities and Drivers
10.3 Challenges
10.4 Porter's Five Forces Analysis
11 Production and Supply Forecast
11.1 Global Forecasted Production of Benign Prostatic Hyperplasia (BPH) Treatment Devices (2021-2026)
11.2 Global Forecasted Revenue of Benign Prostatic Hyperplasia (BPH) Treatment Devices (2021-2026)
11.3 Global Forecasted Price of Benign Prostatic Hyperplasia (BPH) Treatment Devices (2021-2026)
11.4 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Production Forecast by Regions (2021-2026)
11.4.1 North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Production, Revenue Forecast (2021-2026)
11.4.2 Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Production, Revenue Forecast (2021-2026)
11.4.3 China Benign Prostatic Hyperplasia (BPH) Treatment Devices Production, Revenue Forecast (2021-2026)
11.4.4 Japan Benign Prostatic Hyperplasia (BPH) Treatment Devices Production, Revenue Forecast (2021-2026)
12 Consumption and Demand Forecast
12.1 Global Forecasted and Consumption Demand Analysis of Benign Prostatic Hyperplasia (BPH) Treatment Devices
12.2 North America Forecasted Consumption of Benign Prostatic Hyperplasia (BPH) Treatment Devices by Country
12.3 Europe Market Forecasted Consumption of Benign Prostatic Hyperplasia (BPH) Treatment Devices by Country
12.4 Asia Pacific Market Forecasted Consumption of Benign Prostatic Hyperplasia (BPH) Treatment Devices by Regions
12.5 Latin America Forecasted Consumption of Benign Prostatic Hyperplasia (BPH) Treatment Devices
13 Forecast by Type and by Application (2021-2026)
13.1 Global Production, Revenue and Price Forecast by Type (2021-2026)
13.1.1 Global Forecasted Production of Benign Prostatic Hyperplasia (BPH) Treatment Devices by Type (2021-2026)
13.1.2 Global Forecasted Revenue of Benign Prostatic Hyperplasia (BPH) Treatment Devices by Type (2021-2026)
13.1.2 Global Forecasted Price of Benign Prostatic Hyperplasia (BPH) Treatment Devices by Type (2021-2026)
13.2 Global Forecasted Consumption of Benign Prostatic Hyperplasia (BPH) Treatment Devices by Application (2021-2026)
14 Research Finding and Conclusion
15 Methodology and Data Source
15.1 Methodology/Research Approach
15.1.1 Research Programs/Design
15.1.2 Market Size Estimation
15.1.3 Market Breakdown and Data Triangulation
15.2 Data Source
15.2.1 Secondary Sources
15.2.2 Primary Sources
15.3 Author List
15.4 Disclaimer
List of Figures, Tables and Charts Available in Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Research Report 2020
List of TablesTable 1. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Production (K Units) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size by Type (K Units) (US$ Million) (2020 VS 2026)
Table 3. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumption (K Units) Comparison by Application: 2020 VS 2026
Table 4. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Production (K Units) by Manufacturers
Table 5. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Production (K Units) by Manufacturers (2015-2020)
Table 6. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Production Share by Manufacturers (2015-2020)
Table 7. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Share by Manufacturers (2015-2020)
Table 9. Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Benign Prostatic Hyperplasia (BPH) Treatment Devices as of 2019)
Table 10. Global Market Benign Prostatic Hyperplasia (BPH) Treatment Devices Average Price (USD/Unit) of Key Manufacturers (2015-2020)
Table 11. Manufacturers Benign Prostatic Hyperplasia (BPH) Treatment Devices Production Sites and Area Served
Table 12. Manufacturers Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Types
Table 13. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion
Table 15. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Capacity (K Units) by Region (2015-2020)
Table 16. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Production (K Units) by Region (2015-2020)
Table 17. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million US$) by Region (2015-2020)
Table 18. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Region (2015-2020)
Table 19. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 20. North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 21. Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 22. China Benign Prostatic Hyperplasia (BPH) Treatment Devices Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 23. Japan Benign Prostatic Hyperplasia (BPH) Treatment Devices Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 24. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumption (K Units) Market by Region (2015-2020)
Table 25. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumption Market Share by Region (2015-2020)
Table 26. North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumption by Countries (2015-2020) (K Units)
Table 27. Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumption by Countries (2015-2020) (K Units)
Table 28. Asia Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumption by Countries (2015-2020) (K Units)
Table 29. Latin America Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumption by Countries (2015-2020) (K Units)
Table 30. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Production (K Units) by Type (2015-2020)
Table 31. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Production Share by Type (2015-2020)
Table 32. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million US$) by Type (2015-2020)
Table 33. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Share by Type (2015-2020)
Table 34. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Price (USD/Unit) by Type (2015-2020)
Table 35. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumption (K Units) by Application (2015-2020)
Table 36. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumption Market Share by Application (2015-2020)
Table 37. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumption Growth Rate by Application (2015-2020)
Table 38. Endo International (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Production Sites and Area Served
Table 39. Endo International (US) Production Sites and Area Served
Table 40. Endo International (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 41. Endo International (US) Main Business and Markets Served
Table 42. Karl Storz (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Production Sites and Area Served
Table 43. Karl Storz (Germany) Production Sites and Area Served
Table 44. Karl Storz (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 45. Karl Storz (Germany) Main Business and Markets Served
Table 46. Medtronic (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Production Sites and Area Served
Table 47. Medtronic (US) Production Sites and Area Served
Table 48. Medtronic (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 49. Medtronic (US) Main Business and Markets Served
Table 50. Siemens (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Production Sites and Area Served
Table 51. Siemens (Germany) Production Sites and Area Served
Table 52. Siemens (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 53. Siemens (Germany) Main Business and Markets Served
Table 54. Lumenis (Israel) Benign Prostatic Hyperplasia (BPH) Treatment Devices Production Sites and Area Served
Table 55. Lumenis (Israel) Production Sites and Area Served
Table 56. Lumenis (Israel) Benign Prostatic Hyperplasia (BPH) Treatment Devices Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 57. Lumenis (Israel) Main Business and Markets Served
Table 58. Olympus (Japan) Benign Prostatic Hyperplasia (BPH) Treatment Devices Production Sites and Area Served
Table 59. Olympus (Japan) Production Sites and Area Served
Table 60. Olympus (Japan) Benign Prostatic Hyperplasia (BPH) Treatment Devices Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 61. Olympus (Japan) Main Business and Markets Served
Table 62. Urologix (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Production Sites and Area Served
Table 63. Urologix (US) Production Sites and Area Served
Table 64. Urologix (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 65. Urologix (US) Main Business and Markets Served
Table 66. NeoTract (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Production Sites and Area Served
Table 67. NeoTract (US) Production Sites and Area Served
Table 68. NeoTract (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 69. NeoTract (US) Main Business and Markets Served
Table 70. Boston Scientific (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Production Sites and Area Served
Table 71. Boston Scientific (US) Production Sites and Area Served
Table 72. Boston Scientific (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 73. Boston Scientific (US) Main Business and Markets Served
Table 74. Urotech (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Production Sites and Area Served
Table 75. Urotech (Germany) Production Sites and Area Served
Table 76. Urotech (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 77. Urotech (Germany) Main Business and Markets Served
Table 78. Toshiba (Japan) Benign Prostatic Hyperplasia (BPH) Treatment Devices Production Sites and Area Served
Table 79. Toshiba (Japan) Production Sites and Area Served
Table 80. Toshiba (Japan) Benign Prostatic Hyperplasia (BPH) Treatment Devices Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 81. Toshiba (Japan) Main Business and Markets Served
Table 82. Baxter International (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Production Sites and Area Served
Table 83. Baxter International (US) Production Sites and Area Served
Table 84. Baxter International (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 85. Baxter International (US) Main Business and Markets Served
Table 86. Production Base and Market Concentration Rate of Raw Material
Table 87. Key Suppliers of Raw Materials
Table 88. Benign Prostatic Hyperplasia (BPH) Treatment Devices Distributors List
Table 89. Benign Prostatic Hyperplasia (BPH) Treatment Devices Customers List
Table 90. Market Key Trends
Table 91. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 92. Key Challenges
Table 93. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Production (K Units) Forecast by Region (2021-2026)
Table 94. North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumption Forecast 2021-2026 (K Units) by Country
Table 95. Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumption Forecast 2021-2026 (K Units) by Country
Table 96. Asia Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumption Forecast 2021-2026 (K Units) by Regions
Table 97. Latin America Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumption Forecast 2021-2026 (K Units) by Country
Table 98. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumption (K Units) Forecast by Regions (2021-2026)
Table 99. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Production (K Units) Forecast by Type (2021-2026)
Table 100. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million US$) Forecast by Type (2021-2026)
Table 101. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Price (USD/Unit) Forecast by Type (2021-2026)
Table 102. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumption (K Units) Forecast by Application (2021-2026)
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Benign Prostatic Hyperplasia (BPH) Treatment Devices
Figure 2. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Production Market Share by Type: 2020 VS 2026
Figure 3. Laser Based Procedure Product Picture
Figure 4. Other Energy Based Procedure Product Picture
Figure 5. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumption Market Share by Application: 2020 VS 2026
Figure 6. Hospitals
Figure 7. Ambulatory Surgical Centers
Figure 8. Specialty Clinics
Figure 9. Other
Figure 10. North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million US$) and Growth Rate (2015-2026)
Figure 11. Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million US$) and Growth Rate (2015-2026)
Figure 12. China Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million US$) and Growth Rate (2015-2026)
Figure 13. Japan Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million US$) and Growth Rate (2015-2026)
Figure 14. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million US$) (2015-2026)
Figure 15. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Production Capacity (K Units) (2015-2026)
Figure 16. Benign Prostatic Hyperplasia (BPH) Treatment Devices Production Share by Manufacturers in 2019
Figure 17. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Share by Manufacturers in 2019
Figure 18. Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global Market Benign Prostatic Hyperplasia (BPH) Treatment Devices Average Price (USD/Unit) of Key Manufacturers in 2019
Figure 20. The Global 5 and 10 Largest Players: Market Share by Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue in 2019
Figure 21. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Production Market Share by Region (2015-2020)
Figure 22. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Production Market Share by Region in 2019
Figure 23. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Region (2015-2020)
Figure 24. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Region in 2019
Figure 25. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Production (K Units) Growth Rate (2015-2020)
Figure 26. North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Production (K Units) Growth Rate (2015-2020)
Figure 27. Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Production (K Units) Growth Rate (2015-2020)
Figure 28. China Benign Prostatic Hyperplasia (BPH) Treatment Devices Production (K Units) Growth Rate (2015-2020)
Figure 29. Japan Benign Prostatic Hyperplasia (BPH) Treatment Devices Production (K Units) Growth Rate (2015-2020)
Figure 30. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumption Market Share by Region (2015-2020)
Figure 31. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumption Market Share by Region in 2019
Figure 32. North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumption Growth Rate (2015-2020) (K Units)
Figure 33. North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumption Market Share by Countries in 2019
Figure 34. Canada Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumption Growth Rate (2015-2020) (K Units)
Figure 35. U.S. Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumption Growth Rate (2015-2020) (K Units)
Figure 36. Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumption Growth Rate (2015-2020) (K Units)
Figure 37. Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumption Market Share by Countries in 2019
Figure 38. Germany America Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumption Growth Rate (2015-2020) (K Units)
Figure 39. France Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumption Growth Rate (2015-2020) (K Units)
Figure 40. U.K. Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumption Growth Rate (2015-2020) (K Units)
Figure 41. Italy Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumption Growth Rate (2015-2020) (K Units)
Figure 42. Russia Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumption Growth Rate (2015-2020) (K Units)
Figure 43. Asia Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumption Growth Rate (2015-2020) (K Units)
Figure 44. Asia Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumption Market Share by Regions in 2019
Figure 45. China Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumption Growth Rate (2015-2020) (K Units)
Figure 46. Japan Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumption Growth Rate (2015-2020) (K Units)
Figure 47. South Korea Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumption Growth Rate (2015-2020) (K Units)
Figure 48. Taiwan Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumption Growth Rate (2015-2020) (K Units)
Figure 49. Southeast Asia Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumption Growth Rate (2015-2020) (K Units)
Figure 50. India Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumption Growth Rate (2015-2020) (K Units)
Figure 51. Australia Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumption Growth Rate (2015-2020) (K Units)
Figure 52. Latin America Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumption Growth Rate (2015-2020) (K Units)
Figure 53. Latin America Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumption Market Share by Countries in 2019
Figure 54. Mexico Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumption Growth Rate (2015-2020) (K Units)
Figure 55. Brazil Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumption Growth Rate (2015-2020) (K Units)
Figure 56. Production Market Share of Benign Prostatic Hyperplasia (BPH) Treatment Devices by Type (2015-2020)
Figure 57. Production Market Share of Benign Prostatic Hyperplasia (BPH) Treatment Devices by Type in 2019
Figure 58. Revenue Share of Benign Prostatic Hyperplasia (BPH) Treatment Devices by Type (2015-2020)
Figure 59. Revenue Market Share of Benign Prostatic Hyperplasia (BPH) Treatment Devices by Type in 2019
Figure 60. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Production Growth by Type (2015-2020) (K Units)
Figure 61. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumption Market Share by Application (2015-2020)
Figure 62. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumption Market Share by Application in 2019
Figure 63. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumption Growth Rate by Application (2015-2020)
Figure 64. Price Trend of Key Raw Materials
Figure 65. Manufacturing Cost Structure of Benign Prostatic Hyperplasia (BPH) Treatment Devices
Figure 66. Manufacturing Process Analysis of Benign Prostatic Hyperplasia (BPH) Treatment Devices
Figure 67. Benign Prostatic Hyperplasia (BPH) Treatment Devices Industrial Chain Analysis
Figure 68. Channels of Distribution
Figure 69. Distributors Profiles
Figure 70. Porter's Five Forces Analysis
Figure 71. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Production Capacity (K Units) and Growth Rate Forecast (2021-2026)
Figure 72. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Production (K Units) and Growth Rate Forecast (2021-2026)
Figure 73. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 74. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Price and Trend Forecast (2021-2026)
Figure 75. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Production Market Share Forecast by Region (2021-2026)
Figure 76. North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Production (K Units) and Growth Rate Forecast (2021-2026)
Figure 77. North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 78. Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Production (K Units) and Growth Rate Forecast (2021-2026)
Figure 79. Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 80. China Benign Prostatic Hyperplasia (BPH) Treatment Devices Production (K Units) and Growth Rate Forecast (2021-2026)
Figure 81. China Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 82. Japan Benign Prostatic Hyperplasia (BPH) Treatment Devices Production (K Units) and Growth Rate Forecast (2021-2026)
Figure 83. Japan Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 84. Global Forecasted and Consumption Demand Analysis of Benign Prostatic Hyperplasia (BPH) Treatment Devices
Figure 85. North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumption (K Units) Growth Rate Forecast (2021-2026)
Figure 86. Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumption (K Units) Growth Rate Forecast (2021-2026)
Figure 87. Asia Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumption (K Units) Growth Rate Forecast (2021-2026)
Figure 88. Latin America Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumption (K Units) Growth Rate Forecast (2021-2026)
Figure 89. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Production (K Units) Forecast by Type (2021-2026)
Figure 90. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share Forecast by Type (2021-2026)
Figure 91. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumption Forecast by Application (2021-2026)
Figure 92. Bottom-up and Top-down Approaches for This Report
Figure 93. Data Triangulation
Keyplayers in Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Research Report 2020
Endo International (US)Karl Storz (Germany)
Medtronic (US)
Siemens (Germany)
Lumenis (Israel)
Olympus (Japan)
Urologix (US)
NeoTract (US)
Boston Scientific (US)
Urotech (Germany)
Toshiba (Japan)
Baxter International (US)